» Articles » PMID: 7584133

Selective CD28pYMNM Mutations Implicate Phosphatidylinositol 3-kinase in CD86-CD28-mediated Costimulation

Overview
Journal Immunity
Publisher Cell Press
Date 1995 Oct 1
PMID 7584133
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

CD28 costimulatory signals are required for lymphokine production and T cell proliferation. CD28 signaling recruits the intracellular proteins PI 3-kinase, ITK, and GRB-2/SOS. PI 3-kinase and GRB-2/SOS bind the CD28 cytoplasmic pYMNM motif via SH2 domains. We generated CD28 pYMNM mutants and found that Y191 mutation (Y191CD28F) disrupted both PI 3-kinase and GRB-2 binding, while M194 mutation (M194CD28C) disrupted only PI 3-kinase binding. Both mutants still bound ITK. We have assessed the ability of these selective mutants to support IL-2 production upon TCR zeta/CD3 ligation in the presence of CHO-CD86 (B7-2) cells. Both Y191CD28F and M194CD28C mutants failed to generate IL-2. These data directly implicate PI 3-kinase in CD28-mediated costimulation leading to IL-2 secretion. Wortmannin, an inhibitor of PI 3-kinase, induced cell apoptosis and as such was unsuitable for use in this study.

Citing Articles

Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy.

McKenzie C, El-Kholy M, Parekh F, Robson M, Lamb K, Allen C Mol Ther Nucleic Acids. 2023; 32:603-621.

PMID: 37200859 PMC: 10185706. DOI: 10.1016/j.omtn.2023.04.017.


Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.

Cattley R, Lee M, Boggess W, Hawse W J Biol Chem. 2020; 295(24):8236-8251.

PMID: 32358062 PMC: 7294090. DOI: 10.1074/jbc.RA120.012572.


Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.

Yoshida N, Shigemori K, Donaldson N, Trevisani C, Cordero N, Stevenson K Blood. 2020; 135(17):1467-1471.

PMID: 31961925 PMC: 7180081. DOI: 10.1182/blood.2019001815.


Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8 Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy.

Taylor A, Rudd C Front Immunol. 2018; 8:1653.

PMID: 29312284 PMC: 5732207. DOI: 10.3389/fimmu.2017.01653.


ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.

Kunkl M, Porciello N, Mastrogiovanni M, Capuano C, Lucantoni F, Moretti C Front Immunol. 2017; 8:502.

PMID: 28491063 PMC: 5405084. DOI: 10.3389/fimmu.2017.00502.